TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.465
-0.135 (-8.44%)
At close: Aug 13, 2025, 4:00 PM
1.470
+0.005 (0.34%)
After-hours: Aug 13, 2025, 4:10 PM EDT
TELA Bio Employees
TELA Bio had 209 employees as of December 31, 2024. The number of employees decreased by 18 or -7.93% compared to the previous year.
Employees
209
Change (1Y)
-18
Growth (1Y)
-7.93%
Revenue / Employee
$360,397
Profits / Employee
-$195,057
Market Cap
57.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TELA News
- 2 days ago - TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 days ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 23 days ago - TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - GlobeNewsWire
- 2 months ago - TELA Bio Appoints Jeffrey Blizard as President - GlobeNewsWire